![IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect | HTML IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect | HTML](https://www.mdpi.com/ijerph/ijerph-16-02720/article_deploy/html/images/ijerph-16-02720-sch001.png)
IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect | HTML
![Pharmaceuticals | Free Full-Text | Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes | HTML Pharmaceuticals | Free Full-Text | Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00586/article_deploy/html/images/pharmaceuticals-14-00586-g002.png)
Pharmaceuticals | Free Full-Text | Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes | HTML
![Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram](https://www.researchgate.net/profile/Sridhara-Janardhan-3/publication/260680847/figure/fig3/AS:513088665001985@1499341278619/Fig-3-Mechanism-of-action-for-GIP-GLP-1-analogues-and-DPP4-inhibitors-in-controlling.png)
Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram
![Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system | American Journal of Physiology-Heart and Circulatory Physiology Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system | American Journal of Physiology-Heart and Circulatory Physiology](https://journals.physiology.org/cms/10.1152/ajpheart.00209.2014/asset/images/medium/zh40161412100002.jpeg)
Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system | American Journal of Physiology-Heart and Circulatory Physiology
![Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41574-020-0399-8/MediaObjects/41574_2020_399_Fig1_HTML.png)
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus | Nature Reviews Endocrinology
![Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram](https://www.researchgate.net/profile/Iqbal-Malik/publication/23304097/figure/fig2/AS:310188415438849@1450966089391/Mechanism-of-action-of-sitagliptin-vildagliptin-and-exenatide-GLP-1-is-released-from-L.png)
Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram
![ANTIDIABETIC AGENTS Jiří Slíva. DIABETES MELLITUS Multifactorial disease with genetic component Main symptoms: hyperglycemia, metabolic disturbances Relative. - ppt download ANTIDIABETIC AGENTS Jiří Slíva. DIABETES MELLITUS Multifactorial disease with genetic component Main symptoms: hyperglycemia, metabolic disturbances Relative. - ppt download](https://images.slideplayer.com/16/4891899/slides/slide_52.jpg)
ANTIDIABETIC AGENTS Jiří Slíva. DIABETES MELLITUS Multifactorial disease with genetic component Main symptoms: hyperglycemia, metabolic disturbances Relative. - ppt download
![Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction - International Journal of Cardiology Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/53c434b6-5e35-4c09-95ff-8e7da055f4a6/gr1_lrg.jpg)
Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction - International Journal of Cardiology
![Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus - Chen - 2015 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus - Chen - 2015 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e7e1f446-2fc2-4cb2-b120-71f06b03e59f/cep12455-fig-0002-m.jpg)
Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus - Chen - 2015 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
![The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin | Cardiovascular Diabetology | Full Text The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-018-0704-1/MediaObjects/12933_2018_704_Fig2_HTML.gif)
The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin | Cardiovascular Diabetology | Full Text
![Frontiers | Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes | Endocrinology Frontiers | Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes | Endocrinology](https://www.frontiersin.org/files/Articles/440649/fendo-10-00080-HTML-r1/image_m/fendo-10-00080-g001.jpg)
Frontiers | Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes | Endocrinology
![Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? | Pharmacology Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? | Pharmacology](https://www.frontiersin.org/files/Articles/569989/fphar-11-01161-HTML/image_m/fphar-11-01161-g001.jpg)